Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Badimon

Showing results (61-70 of 262) with videos related to

Pageof 27
Sort By:
Expert Opinion on Investigational Drugs|October 27, 2004
Peroxisome proliferator-activated receptor ligands in atherosclerosisJuan F Viles-Gonzalez, Brian G Choi, Valentin Fuster, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1987
Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized bloodL Badimon, J J Badimon, J Rand, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1989
Functional behavior of vessels from pigs with von Willebrand disease. Values of platelet deposition are identical to those obtained on normal vesselsL Badimon, J J Badimon, V T Turitto, et al.
Thrombosis Research|January 1, 1996
A mimetic of the RGDF-peptide [arginine-glycine-aspartic acid-phenylalanine] blocks aggregation and flow-induced platelet deposition on severely injured stenotic arterial wall. Effects on different animal models and in humansC Pueyo, J J Badimon, T Royo, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonistJ I Osende, D Shimbo, V Fuster, et al.
Thrombosis Research|July 1, 2004
Shear stress-dependent platelet function after LDL cholesterol apheresisLukas E Spieker, Frank Ruschitzka, Juan J Badimon, et al.
Current Molecular Medicine|August 22, 2006
Metabolic syndrome and diabetic atherothrombosis: implications in vascular complicationsP Meerarani, J J Badimon, E Zias, et al.
Circulation|December 1, 1988
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulationL Badimon, J J Badimon, V T Turitto, et al.
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Histopathology and pathogenesis of plaque instability and thrombus formationA G Zaman, G Helft, J I Osende, et al.
The American Journal of Cardiology|October 30, 1987
Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategiesP C Adams, V Fuster, L Badimon, et al.
Pageof 27

Showing results (61-70 of 262) with videos related to

Sort By:
Pageof 27
Expert Opinion on Investigational Drugs|October 27, 2004
Peroxisome proliferator-activated receptor ligands in atherosclerosisJuan F Viles-Gonzalez, Brian G Choi, Valentin Fuster, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1987
Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized bloodL Badimon, J J Badimon, J Rand, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1989
Functional behavior of vessels from pigs with von Willebrand disease. Values of platelet deposition are identical to those obtained on normal vesselsL Badimon, J J Badimon, V T Turitto, et al.
Thrombosis Research|January 1, 1996
A mimetic of the RGDF-peptide [arginine-glycine-aspartic acid-phenylalanine] blocks aggregation and flow-induced platelet deposition on severely injured stenotic arterial wall. Effects on different animal models and in humansC Pueyo, J J Badimon, T Royo, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonistJ I Osende, D Shimbo, V Fuster, et al.
Thrombosis Research|July 1, 2004
Shear stress-dependent platelet function after LDL cholesterol apheresisLukas E Spieker, Frank Ruschitzka, Juan J Badimon, et al.
Current Molecular Medicine|August 22, 2006
Metabolic syndrome and diabetic atherothrombosis: implications in vascular complicationsP Meerarani, J J Badimon, E Zias, et al.
Circulation|December 1, 1988
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulationL Badimon, J J Badimon, V T Turitto, et al.
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Histopathology and pathogenesis of plaque instability and thrombus formationA G Zaman, G Helft, J I Osende, et al.
The American Journal of Cardiology|October 30, 1987
Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategiesP C Adams, V Fuster, L Badimon, et al.
Pageof 27